BioCV Denmark ApS: Financial statements 2023
CVR: 43088742
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BioCV Denmark ApS (CVR 43088742) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -182,341 and a net result of DKK -187,958 compared with DKK -28,518 the year before. Equity in the 2023 report amounted to DKK -41,476. The company had 1 employee in the financial year.
- Gross Profit
- DKK -182,341
- Profit/Loss
- DKK -187,958
- Equity
- DKK -41,476
- Total Assets
- DKK 154,530
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -182 t. | -188 t. | -41 t. | 1 |
| 2022 | - | -28 t. | -29 t. | 11 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BioCV Denmark ApS has published its interim report for the period February 25, 2022 to December 31, 2022.
As of October 31, 2023, Moritz Marvin Gansel is registered as director of BioCV Denmark ApS.
As of August 17, 2023, Moritz Marvin Gansel has stepped down as director of BioCV Denmark ApS.
About BioCV Denmark ApS
BioCV Denmark ApS is a Danish company of the type Anpartsselskab based in Tjele, founded in 2022. The company is registered under the industry Computerprogrammering. The management consists of Moritz Marvin Gansel. The company is owned by BioCV GmbH. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -386,126 and a net result of DKK -585,336 compared with DKK -666,047 the year before. Equity in the 2025 report amounted to DKK -1,292,859.